×
Back to Agenda
Opening Plenary Session
Session Chair(s)
E. Stewart Geary, MD
MD, Global Safety Officer, Eisai Co., Ltd., Japan
Pharmacovigilance is among the most critical aspects of a medical product, that ensures that the products are risk-managed in their use. The changing landscape of medicine and evolving technology in pharmaceuticals such as nanotechnology, make the PV requirements more specific. These challenges pronounce more with special events like special audits, mergers and acquisitions.
Speaker(s)
Safety Risk & Pharmacovigilance of Nanoparticles Used in Drugs
Director, Centre of Biomedical Research, India
Advanced Technology As The Strategic Enabler for Pharma R&D
CEO, ArisGlobal, United States
Have an account?